Search results for: Determining Value
Filter search results
Comparative and Relative Effectiveness: A Challenge For Health Systems, Regulators, or Pharmaceutical Companies?
12 January 2014
…assumption that pricing and use will reflect value and, as evidence of value changes, so will price and use.’ He believes EU reforms can encourage improved efficiency in various ways….
An EQ-5D-5L Value Set for England
30 October 2014, 12:00am
…EQ-5D-5L value set for England was a 20 parameter hybrid model (i.e. using both TTO and DCE data) with censored errors/opinions. In this seminar, the new EQ-5D-5L value set…
Time to Tackle the Challenges around Combination Therapies for Cancer
29 March 2021
…methods have been suggested for value attribution, and work is needed to develop and assess these. But while an agreed approach to value attribution could help, the authors see the…
A NICE Wind of Change? The What and So What of the NICE Methods Consultation
7 December 2020
…2020. Value of Information Analysis for Research Decisions—An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. Value in Health, 23(2), pp.139–150. 10.1016/j.jval.2020.01.001. Garau,…
OHE Awarded £457K Grant on Measuring Public Preferences for Health States
2 August 2012
…and observational studies that feed into the NICE HTA process and, ultimately, value based pricing. Already England’s most commonly-used measure of health status, the EQ-5D instrument is accompanied by value…
A Final MVAC Blueprint—and the Start of an R&D Revolution?
6 February 2020
…Blueprint for a Market-Driven Value-Based Advance Commitment (MVAC) for Tuberculosis. Center for Global Development. Available at: https://www.cgdev.org/publication/blueprint-market-driven-value-based-advance-commitment-tuberculosis Related research Chalkidou, K., Garau, M., Nemzoff,C., Rodes-Sanchez, M., Silverman, R., and Towse A. (2019). Blueprint…
Unlocking the broader value of biologic therapies through biosimilar-enabled access and repositioning
23 September 2026
Share this: Download publication Mikel Berdud Paul Oyalo Libby Tungate Lou Garrison Amanda Cole Key messages Biosimilar-Enabled Access and Repositioning (BEAR) can unlock substantial value for patients, health systems and industry —…
Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds
3 March 2020
…OHE Research Paper. Available at https://www.ohe.org/publication s/case-risperidone-assessing-life-cycle-value-second-generation-antipsychotics-sweden-and Pandey, H., 2018. Theoretical models of the cost-effectiveness threshold, value assessment, and health care system sustainability. Institute of Health Economics. Available at https://www.ihe.ca/publications/theoretical-models-of-the-cost-effectiveness-threshold-value-assessment-and-health-care-system-sustainability…
Time Trade Off and Valuing Quality of Life
28 April 2010
…is known as the ‘York MVH’ (Measurement and Valuation of Health) value set. This lists the value for every health state defined by the five-dimension, three-level EQ-5D system. These values…